Evidence map›Paper›PMID 11872095›Full record

ArticleImmunology2002

Age-dependent increase of peritoneal B-1b B cells in SCID mice.

Kirk S Hinkley, Rod J Chiasson, Tracey K Prior, James E Riggs

Open access · greenAbstract read
In one paragraph

Article in Immunology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Noncanonical B Cells: Characteristics of Uncharacteristic B Cells.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kirk S HinkleyDepartment of Biology, Rider University, 2803 Lawrenceville Road, Lawrenceville, NJ 08648-3099, USA.
Rod J Chiasson
Tracey K Prior
James E Riggs
Rider University · US

Funding

RECONSTRUCTION OF SUPERANTIGEN TOLERANT IMMUNITYR15AI037975 · NIAID · RIDER UNIVERSITY · PI RIGGS, JAMES E · 1995 to 1995
–
AGING, IMMUNODEFICIENCY, AND S AGS IN B LYMPHOMAGENESISR15CA077814 · NCI · RIDER UNIVERSITY · PI RIGGS, JAMES E · 1998 to 1999
–
T CELL TOLERANCE INDUCED BY B CELLS IN THE NEONATER15HD029206 · NICHD · RIDER UNIVERSITY · PI RIGGS, JAMES E · 1992 to 1992
–
NCI NIH HHS R15 CA 77814-01NIAID NIH HHS R15 AI 37975-01NICHD NIH HHS R15 HD 29206-01
6 · The paper itself

Abstract

The impact of increasing age upon immunoglobulin production and B-lymphocyte generation in "leaky" severe combined immune-defective (SCID) mice was examined by enzyme-linked immunosorbent assay and flow cytometry. By 1 year of age, the mice had normal numbers of B cells in their peritoneal cavity, while their spleen had very few immunoglobulin M-positive (IgM+) cells. The majority of B cells expressed the CD11b marker characteristic of the B-1b subset. B-1a (CD5+) cells were present at a lower frequency and B-2 cells were absent. The frequency of mice producing detectable immunoglobulin increased with age, and isotype diversity within individual mice was variable. IgM production was most frequently observed followed by IgG3 and IgG2a, then IgG1, and finally IgA. The selective persistence of the B-1 B-cell subset in the peritoneal cavity of aging SCID mice is a natural model for the study of those genetic and environmental influences that determine lymphocyte longevity.

Indexed as

AgingAnimalsB-Lymphocyte SubsetsCD5 AntigensCellular SenescenceImmunoglobulinsMacrophage-1 AntigenMiceMice, SCIDPeritoneal CavitySevere Combined ImmunodeficiencySpleenCD5 AntigensImmunoglobulinsMacrophage-1 Antigen

Identifiers

PMID11872095
PMCPMC1782648
OpenAlexW2040839782

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.